Disorders Due to Use of Multiple Specified Psychoactive Substances, Including Medications (ICD-11: 6C4F)

1. Introduction

Disorders due to use of multiple specified psychoactive substances, including medications, represent a complex and growing challenge in contemporary clinical practice. This condition is characterized by simultaneous or sequential problematic use of different psychoactive substances, including prescribed medications, resulting in significant impairment to the individual's physical health, mental health, and social functioning.

Polysubstance use has become increasingly prevalent in medical practice, reflecting changes in drug use patterns and the availability of multiple substances. Patients frequently combine alcohol with benzodiazepines, opioids with stimulants, or use cannabis together with prescribed medications, creating complex clinical presentations that challenge traditional diagnostic classification.

The clinical importance of this diagnosis lies in the need to properly recognize and address the complexity of simultaneous use of multiple substances. The impact on public health is substantial, with high costs related to medical emergencies, hospital admissions, specialized treatments, and social consequences such as loss of productivity and family breakdown.

Correct coding using code 6C4F is critical for several reasons: it enables appropriate epidemiological tracking, facilitates communication among health professionals, ensures appropriate reimbursement of services provided, and guides public policies based on accurate data. Furthermore, proper documentation is essential for therapeutic planning and to ensure continuity of care at different levels of health care.

2. Correct ICD-11 Code

Code: 6C4F

Description: Disorders due to use of multiple specified psychoactive substances, including medications

Parent category: Disorders due to substance use

Official definition: Disorders due to use of multiple specified psychoactive substances, including medications, are characterized by the pattern and consequences of use of multiple psychoactive substances. Although this grouping is provided for coding purposes, in most clinical situations it is recommended that multiple specific diagnoses due to substance use be assigned, rather than using categories from this grouping.

This code belongs to the chapter on Mental, Behavioral and Neurodevelopmental Disorders of ICD-11, specifically within the section on disorders related to substance use. It is important to highlight that ICD-11 recognizes the complexity of polysubstance use, but directs that, whenever possible, specific codes be used for each substance involved.

Code 6C4F should be used when the pattern of use involves multiple substances in such a way that it is not possible or clinically appropriate to identify a single substance as predominant. The inclusion of "medications" in the description is particularly relevant, as it recognizes the growing problem of inappropriate use of prescribed medications in combination with other substances.

3. When to Use This Code

Code 6C4F should be applied in specific clinical situations where the use of multiple substances constitutes the central problem:

Scenario 1: Polysubstance use without predominant substance Patient who regularly uses alcohol, benzodiazepines, and cannabis, without being able to identify which substance is the primary cause of harm. The pattern of use is alternating, with periods of simultaneous and sequential use, and symptoms of dependence and functional impairment are attributable to the combination of substances, not to a specific one.

Scenario 2: Intentional use of multiple substances for synergistic effects Individual who deliberately combines stimulants (such as amphetamines) with depressants (such as opioids) seeking specific effects, developing dependence on the polysubstance use pattern. The patient has difficulty ceasing the use of any of the substances in isolation, as the combined use pattern has become the central behavior.

Scenario 3: Problematic use of combined prescribed medications Patient with a history of concurrent use of opioids prescribed for chronic pain, benzodiazepines for anxiety, and muscle relaxants, who developed dependence on this combination of medications. Use escalated beyond original prescriptions, with seeking of multiple prescribers and significant impairment in daily life.

Scenario 4: Rapid sequence of different substances Individual who uses different substances in rapid sequence during episodes of compulsive use, such as alcohol followed by cocaine, then benzodiazepines to "come down" from the stimulant effect, establishing a repetitive cycle that characterizes the disorder.

Scenario 5: Situations of incomplete documentation Cases where there is clear evidence of problematic use of multiple substances, but available information does not allow adequate specification of which substances or their individual patterns of use, making the use of the generic code for multiple substances more appropriate.

Scenario 6: Transition between health services Patients in the initial phase of evaluation in emergency services or triage, where there is evidence of intoxication or withdrawal syndrome related to multiple substances, but detailed evaluation has not yet been possible to specify each substance individually.

Essential criteria include: evidence of regular use of at least two different psychoactive substances, development of a problematic pattern of use that causes clinically significant impairment, inability to attribute symptoms predominantly to a single substance, and the need to address polysubstance use as a whole in the therapeutic plan.

4. When NOT to Use This Code

It is essential to understand the situations in which code 6C4F should not be applied, avoiding inadequate coding:

Use of a primary substance with occasional use of others When there is clearly a predominant substance responsible for the main impairments and symptoms, even if the patient occasionally uses other substances, specific codes for the primary substance should be used. For example, a patient with severe alcohol use disorder who occasionally uses cannabis should not receive code 6C4F, but rather 6C40 (disorders due to alcohol use).

Sequential use without significant overlap Patients who present a history of different substance use disorders in different periods of life, but not simultaneously, should receive specific codes for each substance according to the period in question. The history of previous use of other substances should be documented separately.

Isolated acute intoxication Single or rare episodes of simultaneous use of multiple substances resulting in acute intoxication, without an established pattern of problematic use, should be coded with specific intoxication codes for each substance involved.

Adequate therapeutic use of multiple medications Patients who use multiple psychoactive medications as prescribed by appropriate medical prescription, without development of dependence or problematic use, should not receive this code. Appropriate use of prescribed medications does not constitute a substance use disorder.

Primary mental disorders with secondary substance use When substance use is clearly secondary to another primary mental disorder (such as alcohol use for self-medication of severe depression), the primary mental disorder should be coded first, with additional specific codes for each substance used.

Situations where multiple specific codes are more appropriate According to guidance from the code's own definition, in most clinical situations it is preferable to assign multiple specific diagnoses for each substance. Code 6C4F should be reserved for cases where such specification is not possible or clinically appropriate.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Diagnostic confirmation requires comprehensive clinical evaluation including detailed substance use history, complete physical examination, and mental status assessment. The clinician must systematically investigate the use pattern of each substance: frequency, amount, route of administration, context of use, and duration of the problematic pattern.

Standardized instruments can assist in the evaluation, such as structured interviews on substance use, dependency severity scales, and screening questionnaires for polysubstance use. Collateral history from family members or close contacts frequently provides valuable information about the actual use pattern and its impacts.

It is essential to document the impairments associated with use: physical health problems, mental health deterioration, occupational or academic impairment, difficulties in interpersonal relationships, legal problems, and risk situations. The presence of dependence symptoms such as tolerance, withdrawal, loss of control over use, and continued use despite negative consequences must be carefully evaluated.

Laboratory and toxicological tests can confirm recent substance use and assist in identifying specific substances, although they do not replace detailed clinical evaluation.

Step 2: Verify Specifiers

ICD-11 allows additional specification regarding current use pattern and clinical characteristics. One must determine whether the disorder is in continuous use, in initial remission episode, sustained remission, or in controlled environment.

The severity of the disorder can be classified considering the number of diagnostic criteria present, the intensity of symptoms, and the degree of functional impairment. Specific characteristics such as presence of medical complications, psychiatric comorbidities, and risk situations should be documented.

For cases involving medications, it is important to specify whether use began with legitimate prescription or was initiated through other means, as this has different therapeutic and prognostic implications.

Step 3: Differentiate from Other Codes

6C40: Disorders due to use of alcohol This code should be used when alcohol is the primary substance responsible for symptoms and impairments, even if other substances are used occasionally. The key difference is the clear predominance of alcohol in the problematic use pattern.

6C41: Disorders due to use of cannabis Applies when cannabis is the main substance, with an established pattern of problematic use predominantly related to this specific substance. It differs from 6C4F by the absence of significant polysubstance use or by the clear predominance of cannabis.

6C42: Disorders due to use of synthetic cannabinoids Specific for problematic use of synthetic cannabinoids as the primary substance. The important distinction is the specific type of substance and its predominance in the clinical presentation.

The decision between using 6C4F or multiple specific codes should be based on the ability to identify specific substances and the clinical utility of doing so. When possible and clinically relevant, multiple specific codes are preferable.

Step 4: Required Documentation

Adequate documentation should include:

Checklist of mandatory information:

Complete list of all substances used
Use pattern of each substance (frequency, amount, duration)
Route of administration of each substance
Timeline of onset of use for each substance
Dependence symptoms present
Specific impairments related to use
Previous cessation or reduction attempts
Prior treatments and their outcomes
Medical and psychiatric comorbidities
Current social and occupational situation
Risk factors and protective factors identified

The record must explicitly state why code 6C4F was chosen instead of multiple specific codes, documenting the impossibility or inadequacy of specifying a predominant substance. This justification is important for chart reviews and continuity of care.

6. Complete Practical Example

Clinical Case

A 42-year-old patient presents to the mental health service referred by a general practitioner due to progressive deterioration of global functioning over the past three years. During the initial evaluation, he reports daily use of multiple substances in an established and ritualized pattern.

The typical pattern of use includes: in the morning, use of two to three benzodiazepine tablets (obtained through multiple prescriptions and also through non-medical routes); during the day, intermittent alcohol consumption (approximately 6-8 standard drinks); in the late afternoon, cannabis use; at night, additional benzodiazepine use and occasionally sleeping medications from different classes.

The patient reports that this pattern developed gradually following initial benzodiazepine prescription for anxiety five years ago. Progressively, he began combining it with alcohol to potentiate effects, then added cannabis for "additional relaxation." Attempts to discontinue any of the substances individually resulted in intense anxiety, severe insomnia, tremors, and symptoms the patient describes as "unbearable."

Significant impairments include: job loss one year ago, recent marital separation, episodes of falls with minor injuries, impaired memory, progressive social isolation, and debt due to substance-related expenses. He recognizes that the problem is not a specific substance, but the complete pattern of combined use.

Physical examination reveals signs of chronic use of depressant substances: mild tremor of extremities, diminished reflexes, slightly slurred speech. Mental status shows moderate anxiety, depressed mood, partial insight into the severity of the problem. Toxicological tests confirm the presence of benzodiazepines, alcohol, and cannabinoids.

Step-by-Step Coding

Criteria Analysis:

The patient presents with problematic use of at least three different substances (benzodiazepines, alcohol, and cannabis) in an established and ritualized pattern. It is not possible to identify a single substance as predominant, as the pattern of use is integrated and the patient has developed dependence on the set of substances.

Dependence criteria are present: tolerance (need for increasing doses), withdrawal (symptoms when attempting to stop), loss of control (inability to reduce or cease use), continued use despite serious negative consequences, significant time spent obtaining and using substances, and impairment of important activities.

The impairments are clinically significant and affect multiple areas of life. The polysubstance pattern is the central feature of the presentation, and it is not appropriate to attribute the predominant symptoms to a single substance.

Code Selected: 6C4F

Complete Justification:

The code 6C4F - Disorders due to use of multiple specified psychoactive substances, including medications, is the most appropriate because:

There is simultaneous problematic use of multiple substances (benzodiazepines, alcohol, cannabis)
The pattern of use is integrated and ritualized, with substances being used in intentional combination
It is not possible to identify a predominant substance responsible for the main symptoms and impairments
The patient has developed dependence on the polysubstance pattern as a whole
The therapeutic approach must consider the set of substances, not one in isolation
It includes medications (benzodiazepines) obtained both by prescription and through other routes

Complementary Codes:

Additional code to specify comorbidity: anxiety disorder (if present as an independent condition)
Code for specific medical complications, if present
Z code for relevant social circumstances (unemployment, marital problems)

Documentation should include an explanatory note on why multiple specific codes were not used, emphasizing the integrated nature of the polysubstance pattern and the impossibility of attributing predominance to a specific substance.

7. Related Codes and Differentiation

Within the Same Category

6C40: Disorders due to use of alcohol

When to use: Applies when alcohol is clearly the primary substance responsible for symptoms and impairment, even if the patient occasionally uses other substances secondarily.

Main difference vs. 6C4F: In 6C40, alcohol is identifiable as the predominant substance, with an established pattern of problematic use primarily related to alcohol. In 6C4F, there is no single predominant substance or there is integrated use of multiple substances without the ability to identify one as primary.

6C41: Disorders due to use of cannabis

When to use: Indicated when cannabis is the primary substance with an established pattern of problematic use, dependence symptoms, and impairments attributable predominantly to this substance.

Main difference vs. 6C4F: 6C41 requires that cannabis be the predominant substance in the clinical presentation. If there is significant use of other substances without clear predominance of cannabis, or if the polysubstance use pattern is the central characteristic, 6C4F is more appropriate.

6C42: Disorders due to use of synthetic cannabinoids

When to use: Specific for disorders related to use of synthetic cannabinoids (such as K2, Spice) as the primary substance.

Main difference vs. 6C4F: Refers specifically to synthetic cannabinoids, not natural cannabis, and requires that this be the predominant substance. If there is significant polysubstance use including synthetic cannabinoids but without clear predominance, 6C4F may be more appropriate.

Differential Diagnoses

Primary mental disorders with comorbid substance use: Patients with anxiety disorders, depression, or other mental disorders who use multiple substances as a form of self-medication should receive separate diagnoses for the primary mental disorder and for each pattern of substance use, when possible to specify.

Acute intoxication by multiple substances: Acute episodes of intoxication from simultaneous use of substances, without an established pattern of problematic use, should be coded with specific intoxication codes, not with 6C4F which implies an established pattern of disorder.

Iatrogenic use of multiple medications: Patients who develop dependence on medications appropriately prescribed by multiple physicians for legitimate conditions, without drug-seeking behavior or non-medical use, may require different coding focused on complications of medical treatment.

Clear distinction between these diagnoses requires careful evaluation of temporality, pattern of use, presence of dependence symptoms, and nature of the impairments presented.

8. Differences with ICD-10

In ICD-10, the closest equivalent code is F19 - Mental and behavioral disorders due to multiple drug use and use of other psychoactive substances. The ICD-10 structure used the alphanumeric system with additional subdivisions to specify the current state (F19.0 for acute intoxication, F19.2 for dependence syndrome, etc.).

The main changes in ICD-11 include greater conceptual clarity and emphasis on the recommendation to use multiple specific codes whenever possible, rather than the generic code for multiple substances. ICD-11 also provides more precise definitions about when the code for multiple substances is appropriate versus when multiple specific codes should be preferred.

Another significant change is the explicit inclusion of "medications" in the description of code 6C4F, formally recognizing the growing problem of inappropriate use of prescribed medications in combination with other substances. ICD-10 was less specific in this regard.

The structure of specifiers was also modified in ICD-11, with a more flexible and clinically relevant system to indicate the current pattern of use, remission, and specific characteristics of the disorder. This allows for more precise documentation of the patient's current clinical state.

The practical impact of these changes includes greater diagnostic accuracy, better epidemiological tracking of polysubstance use, and clearer guidance for clinicians on when to use generic versus specific codes. The transition requires adequate training of professionals to understand these nuances and apply them correctly in clinical practice.

9. Frequently Asked Questions

How is the diagnosis of multiple substance use disorders made?

Diagnosis requires comprehensive clinical evaluation including detailed history of use of each substance, physical examination, mental status assessment and, when indicated, laboratory and toxicological tests. The clinician should systematically investigate the pattern of use, dependence symptoms, associated impairments and previous cessation attempts. Standardized assessment instruments may assist, but do not replace clinical judgment. Collateral history from family members or close contacts frequently provides valuable information. Diagnosis is established when there is evidence of problematic use of multiple substances causing clinically significant impairment, without the possibility of identifying a single substance as predominant.

Is treatment available in public health systems?

In many countries, public health systems offer treatment for substance use disorders, including cases of polysubstance use, although availability and scope vary considerably. Services may include supervised detoxification, outpatient treatment, inpatient care when necessary, psychological therapies, support groups and, when indicated, pharmacological treatment. Access may be through specialized addiction services, mental health services or general clinics with trained teams. It is recommended to seek information from local health services about available programs and eligibility criteria.

How long does treatment last?

Treatment duration varies widely depending on the severity of the disorder, number and types of substances involved, presence of comorbidities, available social support and individual response to treatment. The initial detoxification phase may last days to weeks, depending on the substances. Active treatment generally requires months, with many structured programs lasting three to six months. However, management of multiple substance use disorders frequently requires long-term follow-up, sometimes for years, to prevent relapse and consolidate recovery. Many patients benefit from continued support through support groups or less intensive follow-up after the active treatment phase.

Can this code be used in medical certificates?

Yes, code 6C4F can be used in official medical documentation, including certificates, when appropriate. However, considerations of confidentiality and stigma should be weighed. In some contexts, it may be appropriate to use more general terms or less specific codes in documents that will be seen by non-medical third parties, while maintaining detailed documentation in the medical record. Legislation on medical privacy and patient rights varies between jurisdictions, but generally protects information about substance use disorders. The patient should be informed about what will be documented and have the opportunity to discuss confidentiality concerns.

What is the difference between using code 6C4F and multiple specific codes?

The ICD-11 definition itself indicates that in most clinical situations, it is preferable to use multiple specific codes for each substance involved, as this provides more detailed and clinically useful information. Code 6C4F should be reserved for situations where it is not possible to identify specific predominant substances, where the polysubstance use pattern is so integrated that it does not make sense to separate it, or in early stages of evaluation when detailed information is not yet available. Multiple specific codes allow better epidemiological tracking, more precise therapeutic planning and clearer communication between professionals.

Can patients using medications prescribed according to medical guidance receive this diagnosis?

No. Appropriate use of medications as prescribed by a physician, even if involving multiple psychoactive medications, does not constitute a substance use disorder. Diagnosis requires the presence of a problematic pattern of use with dependence symptoms and clinically significant impairment. However, patients may develop dependence even when use began with legitimate prescription, especially if they escalated doses beyond what was prescribed, seek multiple prescribers, use medications from other people or exhibit compulsive drug-seeking behaviors. In these cases, even with an initial prescription, a substance use disorder may be present.

How to differentiate occasional recreational use of multiple substances from a disorder?

Differentiation is based on the presence of specific diagnostic criteria: dependence symptoms (tolerance, withdrawal, loss of control), clinically significant impairment in important areas of life (health, work, relationships), continued use despite negative consequences, significant time spent obtaining and using substances, and impairment of previously valued activities. Occasional recreational use, by definition, does not present these criteria. The frequency and quantity of use, although relevant, are not by themselves determinants of diagnosis - the critical element is the presence of impairment and loss of control over use.

Is complete recovery from multiple substance use disorders possible?

Yes, many people achieve sustained recovery from multiple substance use disorders, although the process can be challenging and require continued support. Recovery is better understood as a continuous process than a single event, often involving periods of remission, possible relapses and re-engagement in treatment. Factors associated with better outcomes include: adequate and timely treatment, strong social support, absence or adequate management of psychiatric comorbidities, housing and occupational stability, and engagement in meaningful activities and healthy relationships. Many people in long-term recovery report significantly improved quality of life and full functioning in all areas of life.

Conclusion:

Code 6C4F of ICD-11 represents an important tool for coding complex cases of polysubstance use of psychoactive substances. Although the general guidance is to use multiple specific codes whenever possible, this code has appropriate application in specific clinical situations where the integrated pattern of use of multiple substances is the central feature. Appropriate coding requires clear understanding of diagnostic criteria, specific indications for use of this code, and differences in relation to other related codes. Careful documentation and judicious clinical judgment are essential to ensure that coding adequately reflects the complexity of the clinical presentation and guides appropriate therapeutic planning.

External References

This article was developed based on reliable scientific sources:

References verified on 2026-02-03

Disorders due to use of multiple specified psychoactive substances, including medications

Partager